<DOC>
	<DOCNO>NCT01336153</DOCNO>
	<brief_summary>To investigate safety efficacy MLC601 ( NeuroAideTM ) Traditional Chinese Medicine motor recovery ischemic stroke .</brief_summary>
	<brief_title>Clinical Study Investigate Safety Efficacy MLC601 150 Iranian Patients After Stroke</brief_title>
	<detailed_description>This double-blind , placebo-controlled clinical trial study 150 patient recent ( less 3 month ) ischemic stroke . All patient give either MLC601 ( 100 patient ) placebo ( 50 patient ) , 4 capsule 3 time day , add-on standard medication post stroke 3 month . Motor improvement monitor use Fugl-Meyer Assessment FMA .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>age 3072 yars , &lt; one month stroke , ischemic cerebral stroke , sign informed consent form . treatment thrombolytic stoke , ischemic stroke combine hemorrhage , severe renal liver failure , dementia , psychosis history seizure disorder , history previous stroke , hemoglobin level less 10mg/dl admission .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>MLC601</keyword>
	<keyword>motor recovery</keyword>
</DOC>